1.
Machine Learning-Based Radiomic Signatures for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer. J. Can. Res. Updates [Internet]. 2026 Oct. 30 [cited 2026 Oct. 30];15(4):360-7. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/1007